{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:55:31Z","timestamp":1794534931607,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802510"],"award-info":[{"award-number":["81802510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypoxia-inducible factor 1\u03b1 (HIF1\u03b1) promotes the malignant progression of glioblastoma under hypoxic conditions, leading to a poor prognosis for patients with glioblastoma; however, none of the therapies targeting HIF1\u03b1 in glioblastoma have successfully eradicated the tumour. Therefore, we focused on the reason and found that treatments targeting HIF1\u03b1 and HIF2\u03b1 simultaneously increased tumour volume, but the combination of HIF1\u03b1\/HIF2\u03b1-targeted therapies with temozolomide (TMZ) reduced tumourigenesis and significantly improved chemosensitization. Moreover, miR-210-3p induced HIF1\u03b1 expression but inhibited HIF2\u03b1 expression, suggesting that miR-210-3p regulates HIF1\u03b1\/HIF2\u03b1 expression. Epidermal growth factor (EGF) has been shown to upregulate HIF1\u03b1 expression under hypoxic conditions. However, in the present study, in addition to the signalling pathways mentioned above, the upstream proteins HIF1\u03b1 and HIF2\u03b1 have been shown to induce EGF expression by binding to the sequences AGGCGTGG and GGGCGTGG. Briefly, in a hypoxic microenvironment the HIF1\u03b1\/HIF2\u03b1-miR210-3p network promotes the malignant progression of glioblastoma through a positive feedback loop with EGF. Additionally, differentiated glioblastoma cells underwent dedifferentiation to produce glioma stem cells under hypoxic conditions, and simultaneous knockout of HIF1\u03b1 and HIF2\u03b1 inhibited cell cycle arrest but promoted proliferation with decreased stemness, promoting glioblastoma cell chemosensitization. In summary, both HIF1\u03b1 and HIF2\u03b1 regulate glioblastoma cell proliferation, dedifferentiation and chemoresistance through a specific pathway, which is important for glioblastoma treatments.<\/jats:p>","DOI":"10.1038\/s41419-020-03150-0","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T14:08:00Z","timestamp":1605708480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["The HIF1\u03b1\/HIF2\u03b1-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions"],"prefix":"10.1038","volume":"11","author":[{"given":"Pan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanglong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangmin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-2791","authenticated-orcid":false,"given":"Sheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"3150_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-4939-7659-1_9","volume":"1741","author":"JP Gagner","year":"2018","unstructured":"Gagner, J. P., Lechpammer, M. & Zagzag, D. Induction and assessment of hypoxia in glioblastoma cells in vitro. Methods Mol. Biol. 1741, 111\u2013123 (2018).","journal-title":"Methods Mol. Biol."},{"key":"3150_CR2","doi-asserted-by":"crossref","unstructured":"Wang, P. et al. HIF1\u03b1 regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia. Oncotarget 8, 28074\u201328092 (2017).","DOI":"10.18632\/oncotarget.15888"},{"key":"3150_CR3","doi-asserted-by":"publisher","first-page":"iii57","DOI":"10.1093\/neuonc\/nox036.204","volume":"19","author":"JJ Renfrow","year":"2017","unstructured":"Renfrow, J. J. et al. P08.14 In situ detection of hypoxia inducible factor 2 alpha in malignant gliomas. Neuro-Oncol. 19, iii57\u2013iii57 (2017).","journal-title":"Neuro-Oncol."},{"key":"3150_CR4","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nm.2865","volume":"18","author":"RM Young","year":"2012","unstructured":"Young, R. M. & Simon, M. C. Untuning the tumor metabolic machine: HIF-\u03b1: pro- and antitumorigenic? Nat. Med. 18, 1024\u20131025 (2012).","journal-title":"Nat. Med."},{"key":"3150_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","volume":"15","author":"Z Li","year":"2009","unstructured":"Li, Z. et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15, 501\u2013513 (2009).","journal-title":"Cancer Cell"},{"key":"3150_CR6","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-10-4142","volume":"71","author":"MY Koh","year":"2011","unstructured":"Koh, M. Y., Lemos, R., Liu, X. & Powis, G. The hypoxia-associated factor switches cells from HIF-1\u03b1- to HIF-2\u03b1-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Res. 71, 4015\u20134027 (2011).","journal-title":"Cancer Res."},{"key":"3150_CR7","doi-asserted-by":"publisher","first-page":"vi253","DOI":"10.1093\/neuonc\/nox168.1034","volume":"19","author":"E Johansson","year":"2017","unstructured":"Johansson, E. et al. TMIC-46. tuning of hypoxic and pseudo-hypoxic glioma phenotypes in perivascular and perinecrotic niches. Neuro-Oncol. 19, vi253\u2013vi253 (2017).","journal-title":"Neuro-Oncol."},{"key":"3150_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc3183","volume":"12","author":"B Keith","year":"2011","unstructured":"Keith, B., Johnson, R. S. & Simon, M. C. HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression. Nat. Rev. Cancer 12, 9\u201322 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"3150_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.stem.2017.10.005","volume":"22","author":"J Man","year":"2017","unstructured":"Man, J. et al. Hypoxic induction of vasorin regulates Notch1 turnover to maintain glioma stem-like cells. Cell Stem Cell 22, 104\u2013118 (2017).","journal-title":"Cell Stem Cell"},{"key":"3150_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06086-2","volume":"7","author":"P Wang","year":"2017","unstructured":"Wang, P. et al. HIF1\u03b1 regulates glioma chemosensitivity through the transformation between differentiation and dedifferentiation in various oxygen levels. Sci. Rep. 7, 7965 (2017).","journal-title":"Sci. Rep."},{"key":"3150_CR11","doi-asserted-by":"publisher","first-page":"17392","DOI":"10.1002\/jcp.28361","volume":"234","author":"M Wei","year":"2019","unstructured":"Wei, M. et al. Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1\u03b1\/hedgehog pathway under hypoxia. J. Cell. Physiol. 234, 17392\u201317404 (2019).","journal-title":"J. Cell. Physiol."},{"key":"3150_CR12","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1002\/jcp.29396","volume":"235","author":"M Abolghasemi","year":"2019","unstructured":"Abolghasemi, M. et al. MicroRNAs in breast cancer: Roles, functions, and mechanism of actions. J. Cell. Physiol. 235, 5008\u20135029 (2019).","journal-title":"J. Cell. Physiol."},{"key":"3150_CR13","doi-asserted-by":"publisher","first-page":"pii:E265","DOI":"10.3390\/cancers11020265","volume":"11","author":"SG Wu","year":"2019","unstructured":"Wu, S. G., Chang, T. H., Liu, Y. N. & Shih, J. Y. MicroRNA in lung cancer metastasis. Cancers (Basel) 11, pii:E265 (2019).","journal-title":"Cancers (Basel)"},{"key":"3150_CR14","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.ymthe.2019.07.011","volume":"27","author":"X Yue","year":"2019","unstructured":"Yue, X., Lan, F. & Xia, T. Hypoxic glioma cell-secreted exosomal miR-301a activates Wnt\/\u03b2-catenin signaling and promotes radiation resistance by targeting TCEAL7. Mol. Ther. 27, 1939\u20131949 (2019).","journal-title":"Mol. Ther."},{"key":"3150_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ccell.2015.12.005","volume":"29","author":"J Hu","year":"2016","unstructured":"Hu, J. et al. MiR-215 is induced post-transcriptionally via HIF-drosha complex and mediates glioma-initiating cell adaptation to hypoxia by targeting KDM1B. Cancer Cell 29, 49\u201360 (2016).","journal-title":"Cancer Cell"},{"key":"3150_CR16","doi-asserted-by":"publisher","first-page":"118789","DOI":"10.1016\/j.ijpharm.2019.118789","volume":"572","author":"A Jana","year":"2019","unstructured":"Jana, A., Narula, P., Chugh, A. & Kulshreshtha, R. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment. Int J. Pharm. 572, 118789 (2019).","journal-title":"Int J. Pharm."},{"key":"3150_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-686","volume":"15","author":"R Agrawal","year":"2014","unstructured":"Agrawal, R. et al. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing. BMC Genomics 15, 686 (2014).","journal-title":"BMC Genomics"},{"key":"3150_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.canlet.2012.10.029","volume":"329","author":"JC Cheng","year":"2013","unstructured":"Cheng, J. C., Klausen, C. & Leung, P. C. Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells. Cancer Lett. 329, 197\u2013206 (2013).","journal-title":"Cancer Lett."},{"key":"3150_CR19","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/hed.23733","volume":"37","author":"P Secades","year":"2015","unstructured":"Secades, P., de Santa-Mar\u00eda, I. S., Merlo, A., Suarez, C. & Chiara, M. D. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy. Head. Neck 37, 1150\u20131162 (2015).","journal-title":"Head. Neck"},{"key":"3150_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6582","volume":"5","author":"AT Henze","year":"2014","unstructured":"Henze, A. T. et al. Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR. Nat. Commun. 5, 5582 (2014).","journal-title":"Nat. Commun."},{"key":"3150_CR21","doi-asserted-by":"crossref","unstructured":"Zheng, H. L. et al. Oligomer procyanidins (F2) repress HIF-1\u03b1 expression in human U87 glioma cells by inhibiting the EGFR\/ AKT\/mTOR and MAPK\/ERK1\/2 signaling pathways in vitro and in vivo. Oncotarget 8, 85252\u201385262 (2017).","DOI":"10.18632\/oncotarget.19654"},{"key":"3150_CR22","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00259-019-04621-z","volume":"47","author":"M Hu","year":"2020","unstructured":"Hu, M. et al. Correlation of hypoxia as measured by fluorine-8 fluoroerythronitroimidazole (18F-FETNIM) PET\/CT and overall survival in glioma patients. Eur. J. Nucl. Med Mol. Imaging 47, 1427\u20131434 (2020).","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"3150_CR23","first-page":"16105","volume":"3","author":"P Wang","year":"2017","unstructured":"Wang, P., Wan, W.-w, Xiong, S.-L., Feng, H. & Wu, N. Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer. Cell Death. Discovery 3, 16105 (2017).","journal-title":"Discovery"},{"key":"3150_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.yexcr.2016.04.011","volume":"343","author":"JH Tang","year":"2016","unstructured":"Tang, J. H. et al. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment. Exp. Cell Res. 343, 148\u2013158 (2016).","journal-title":"Exp. Cell Res."},{"key":"3150_CR25","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.4155\/fmc-2018-0163","volume":"10","author":"JJ Renfrow","year":"2018","unstructured":"Renfrow, J. J. et al. Hypoxia-inducible factor 2\u03b1: a novel target in gliomas. Future Med. Chem. 10, 2227\u20132236 (2018).","journal-title":"Future Med. Chem."},{"key":"3150_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nature16475","volume":"529","author":"SB Lee","year":"2016","unstructured":"Lee, S. B. et al. An ID2-dependent mechanism for VHL inactivation in cancer. Nature 529, 172\u2013177 (2016).","journal-title":"Nature"},{"key":"3150_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11060-008-9742-y","volume":"92","author":"Z Chen","year":"2009","unstructured":"Chen, Z. et al. In vitro angiogenesis by human umbilical vein endothelial cells (HUVEC) induced by three-dimensional co-culture with glioblastoma cells. J. Neurooncol. 92, 121\u2013128 (2009).","journal-title":"J. Neurooncol."},{"key":"3150_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.biocel.2016.02.017","volume":"74","author":"M Bhagat","year":"2016","unstructured":"Bhagat, M. et al. HIF-2\u03b1 mediates a marked increase in migration and stemness characteristics in a subset of Glioma cells under hypoxia by activating an Oct-4\/Sox-2- Mena (INV) axis. Int. J. Biochem. Cell Biol. 74, 60\u201371 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"3150_CR29","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2014.9.FOCUS14496","volume":"37","author":"M Womeldorff","year":"2014","unstructured":"Womeldorff, M., Gillespie, D. & Jensen, R. L. Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurgical Focus 37, E8 (2014).","journal-title":"Neurosurgical Focus"},{"key":"3150_CR30","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1158\/1535-7163.MCT-15-0675","volume":"15","author":"G Lee","year":"2016","unstructured":"Lee, G. et al. Dedifferentiation of glioma cells to glioma stem-like cells by therapeutic stress-induced HIF signaling in the recurrent GBM model. Mol. Cancer Ther. 15, 3064\u20133076 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"3150_CR31","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/cdd.2014.31","volume":"21","author":"B Auffinger","year":"2014","unstructured":"Auffinger, B. et al. Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy. Cell Death Differ. 21, 1119\u20131131 (2014).","journal-title":"Cell Death Differ."},{"key":"3150_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.509","volume":"5","author":"P Dahan","year":"2014","unstructured":"Dahan, P. et al. Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance. Cell death Dis. 5, e1543 (2014).","journal-title":"Cell death Dis."},{"key":"3150_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.7150\/ijms.5407","volume":"10","author":"P Li","year":"2013","unstructured":"Li, P., Zhou, C., Xu, L. & Xiao, H. Hypoxia enhances stemness of cancer stem cells in glioblastoma: an in vitro study. Int. J. Med. Sci. 10, 399\u2013407 (2013).","journal-title":"Int. J. Med. Sci."},{"key":"3150_CR34","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2353\/ajpath.2010.091021","volume":"177","author":"EE Bar","year":"2010","unstructured":"Bar, E. E., Lin, A., Mahairaki, V., Matsui, W. & Eberhart, C. G. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am. J. Pathol. 177, 1491\u20131502 (2010).","journal-title":"Am. J. Pathol."},{"key":"3150_CR35","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1158\/0008-5472.CAN-10-3320","volume":"71","author":"J Mathieu","year":"2011","unstructured":"Mathieu, J. et al. HIF induces human embryonic stem cell markers in cancer cells. Cancer Res. 71, 4640\u20134652 (2011).","journal-title":"Cancer Res."},{"key":"3150_CR36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396\u2013401 (2004).","journal-title":"Nature"},{"key":"3150_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrc2468","volume":"8","author":"NC Denko","year":"2008","unstructured":"Denko, N. C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 8, 705\u2013713 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"3150_CR38","doi-asserted-by":"crossref","unstructured":"Kumar, H. & Choi, D. K. Hypoxia inducible factor pathway and physiological adaptation: a cell survival pathway? Mediators Inflamm. 2015, 584758 (2015).","DOI":"10.1155\/2015\/584758"},{"key":"3150_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50375-x","volume":"9","author":"J Li","year":"2019","unstructured":"Li, J. et al. ELTD1 facilitates glioma proliferation, migration and invasion by activating JAK\/STAT3\/HIF-1\u03b1 signaling axis. Sci. Rep. 9, 13904 (2019).","journal-title":"Sci. Rep."},{"key":"3150_CR40","doi-asserted-by":"publisher","first-page":"E5429","DOI":"10.1073\/pnas.1421438111","volume":"111","author":"D Samanta","year":"2014","unstructured":"Samanta, D., Gilkes, D. M., Chaturvedi, P., Xiang, L. & Semenza, G. L. Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc. Natl Acad. Sci. USA 111, E5429\u2013E5438 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3150_CR41","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1242\/jcs.035022","volume":"122","author":"MC Brahimi-Horn","year":"2009","unstructured":"Brahimi-Horn, M. C. & Pouyss\u00e9gur, J. HIF at a glance. J. Cell. Sci. 122, 1055\u20131057 (2009).","journal-title":"J. Cell. Sci."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03150-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:42:24Z","timestamp":1670254944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03150-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["3150"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03150-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"22 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"992"}}